|
1
|
Cancer risk assessment, indicators, and guidelines for polycyclic aromatic hydrocarbons in the ambient air.
|
Environ Health Perspect
|
2002
|
4.07
|
|
2
|
The aryl hydrocarbon receptor in immunity.
|
Trends Immunol
|
2009
|
2.19
|
|
3
|
Lightening up the UV response by identification of the arylhydrocarbon receptor as a cytoplasmatic target for ultraviolet B radiation.
|
Proc Natl Acad Sci U S A
|
2007
|
2.08
|
|
4
|
The suggested physiologic aryl hydrocarbon receptor activator and cytochrome P4501 substrate 6-formylindolo[3,2-b]carbazole is present in humans.
|
J Biol Chem
|
2008
|
1.74
|
|
5
|
Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk.
|
Carcinogenesis
|
2002
|
1.73
|
|
6
|
Identification of the tryptophan photoproduct 6-formylindolo[3,2-b]carbazole, in cell culture medium, as a factor that controls the background aryl hydrocarbon receptor activity.
|
Toxicol Sci
|
2005
|
1.52
|
|
7
|
CYP1A1 and GSTM1 genetic polymorphisms and lung cancer risk in Caucasian non-smokers: a pooled analysis.
|
Carcinogenesis
|
2003
|
1.28
|
|
8
|
Inhibition of cytochrome P4501-dependent clearance of the endogenous agonist FICZ as a mechanism for activation of the aryl hydrocarbon receptor.
|
Proc Natl Acad Sci U S A
|
2012
|
1.19
|
|
9
|
Influence of CYP1A1, GSTM1, GSTT1, and NQO1 genotypes and cumulative smoking dose on lung cancer risk in a Swedish population.
|
Cancer Epidemiol Biomarkers Prev
|
2004
|
1.15
|
|
10
|
CYP1A1 T3801 C polymorphism and lung cancer: a pooled analysis of 2451 cases and 3358 controls.
|
Int J Cancer
|
2003
|
1.13
|
|
11
|
Microsomal epoxide hydrolase polymorphisms and lung cancer risk: a quantitative review.
|
Biomarkers
|
2002
|
1.11
|
|
12
|
Pooled analysis of the CYP1A1 exon 7 polymorphism and lung cancer (United States).
|
Cancer Causes Control
|
2003
|
1.04
|
|
13
|
CYP1A1, GSTM1 and GSTT1 polymorphisms and lung cancer: a pooled analysis of gene-gene interactions.
|
Biomarkers
|
2005
|
1.02
|
|
14
|
Metabolic fate of the Ah receptor ligand 6-formylindolo[3,2-b]carbazole.
|
Chem Biol Interact
|
2004
|
0.99
|
|
15
|
The aryl hydrocarbon receptor mediates UVB radiation-induced skin tanning.
|
J Invest Dermatol
|
2010
|
0.97
|
|
16
|
The aryl hydrocarbon receptor (AHR), a novel regulator of human melanogenesis.
|
Pigment Cell Melanoma Res
|
2010
|
0.96
|
|
17
|
Evidence of gene gene interactions in lung carcinogenesis in a large pooled analysis.
|
Carcinogenesis
|
2007
|
0.96
|
|
18
|
An international case-control study of glutathione transferase and functionally related polymorphisms and risk of primary adult brain tumors.
|
Cancer Epidemiol Biomarkers Prev
|
2007
|
0.95
|
|
19
|
Identification of amino acid residues in the Ah receptor involved in ligand binding.
|
Biochem Biophys Res Commun
|
2007
|
0.94
|
|
20
|
Metabolic gene polymorphisms and lung cancer risk in non-smokers. An update of the GSEC study.
|
Mutat Res
|
2005
|
0.94
|
|
21
|
Association of metabolic gene polymorphisms with tobacco consumption in healthy controls.
|
Int J Cancer
|
2004
|
0.89
|
|
22
|
Quercetin, resveratrol, and curcumin are indirect activators of the aryl hydrocarbon receptor (AHR).
|
Chem Res Toxicol
|
2012
|
0.85
|
|
23
|
Influence of metabolic genotypes on biomarkers of exposure to 1,3-butadiene in humans.
|
Cancer Epidemiol Biomarkers Prev
|
2002
|
0.84
|
|
24
|
The GSTP1 Ile105 Val polymorphism modifies the metabolism of toluene di-isocyanate.
|
Pharmacogenet Genomics
|
2010
|
0.84
|
|
25
|
A study on diurnal mRNA expression of CYP1A1, AHR, ARNT, and PER2 in rat pituitary and liver.
|
Environ Toxicol Pharmacol
|
2002
|
0.83
|
|
26
|
Short-term exposure to dioxin impairs bone tissue in male rats.
|
Chemosphere
|
2009
|
0.82
|
|
27
|
The effect of relevant genotypes on PAH exposure-related biomarkers.
|
J Expo Anal Environ Epidemiol
|
2002
|
0.82
|
|
28
|
In vitro studies of the influence of glutathione transferases and epoxide hydrolase on the detoxification of acrylamide and glycidamide in blood.
|
Mutat Res
|
2005
|
0.81
|
|
29
|
Characterization of in vitro metabolites of the aryl hydrocarbon receptor ligand 6-formylindolo[3,2-b]carbazole by liquid chromatography-mass spectrometry and NMR.
|
Drug Metab Dispos
|
2003
|
0.81
|
|
30
|
Susceptibility factors and DNA adducts in peripheral blood mononuclear cells of aluminium smelter workers exposed to polycyclic aromatic hydrocarbons.
|
Arch Toxicol
|
2002
|
0.81
|
|
31
|
TCDD-induced expression of Ah receptor responsive genes in the pituitary and brain of cellular retinol-binding protein (CRBP-I) knockout mice.
|
Toxicol Appl Pharmacol
|
2003
|
0.80
|
|
32
|
Expression of hypothalamic neuropeptides after acute TCDD treatment and distribution of Ah receptor repressor.
|
Regul Pept
|
2004
|
0.79
|
|
33
|
Detection and characterization of a novel functional polymorphism in the GSTT1 gene.
|
Pharmacogenetics
|
2002
|
0.79
|
|
34
|
Constitutive CYP1B1 mRNA expression in human blood mononuclear cells in relation to gender, genotype, and environmental factors.
|
Environ Res
|
2003
|
0.77
|
|
35
|
Influence of genetic factors on toluene diisocyanate-related symptoms: evidence from a cross-sectional study.
|
Environ Health
|
2008
|
0.76
|
|
36
|
In vitro studies of the influence of certain enzymes on the detoxification of acrylamide and glycidamide in blood.
|
Adv Exp Med Biol
|
2005
|
0.75
|